Ameritas Investment Partners, Inc. Novo Cure LTD Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 11,141 shares of NVCR stock, worth $224,825. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,141
Previous 10,433
6.79%
Holding current value
$224,825
Previous $163,000
103.68%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$245 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$238 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$179 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$97.2 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$55.3 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.12B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...